Results 161 to 170 of about 3,513 (190)

Real time, on-site drug checking in low-threshold housing communities. [PDF]

Harm Reduct J
Summers C, Silcox J, Zaragoza S, Rapisarda S, Edelmann A, Chatterjee A, Green TC.   +6 more
europepmc   +1 more source

Identifying Factors Associated With Intentional and Unintentional Fentanyl Use Among People Who Use Drugs in New York City. [PDF]

J Addict Med
Khezri M, Choe K, Griffin B, Bunting AM.
europepmc   +1 more source

Point-Of-Care Drug-Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances. [PDF]

Drug Alcohol Rev
Ujeneza M, Tardif J, Thompson E, Badea A, Morales A, Altomare-Jarczyk C, Green TC, Serafinski R, McKenzie M, Park JN.   +9 more
europepmc   +1 more source

Thyroid hormone disrupting chemicals and their influence on the developing rat brain [PDF]

, 2011
Petersen, Marta Axelstad
core  

Urgent response is needed to address the stimulant-fentanyl related overdose crisis. [PDF]

Front Psychiatry
Mills R, Jegede O, Muvvala SB.
europepmc   +1 more source

Barriers and facilitators to initiating and adhering to harm reduction services among people who inject drugs in the United States: a systematic review. [PDF]

Harm Reduct J
Nacht CL, Skaathun B, Ogarrio K, Durbin-Matrone R, Wright L, Reich R, Reich K, Stojanovski K.   +7 more
europepmc   +1 more source

Association of fentanyl test strip results and change in drug use behaviors: A multi-state, community-based observational study

Kitty H. Gelberg, Nabila El–Bassel, Denise C. Babineau, Rachel Vickers‐Smith, Laura Fanucchi, Janet E. Childerhose, Megan E. Hall, Megan E. Dzurec, Jennifer Villani, Mary Russo, Patricia LeBaron, Katherine R. Marks, K. Lancaster, Louisa Gilbert, James L. David, Barry Eggleston, Carter Roeber, Emmanuel Oga, Redonna K. Chandler, Sharon Walsh   +19 more
openalex   +1 more source

The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV. [PDF]

Addict Sci Clin Pract
Appa A, Marti XL, Baral S, Shoptaw S, Bazazi AR, Spinelli MA, Glidden D, Gandhi M, Coffin P.   +8 more
europepmc   +1 more source